SunCar Technology Reports 2024 Annual Results
NEW YORK, April 29, 2025 /PRNewswire/ -- SunCar Technology Group Inc. (the "Company" or "SunCar") (NASDAQ: SDA), an innovative leader in cloud-based, software-focused B2B auto eInsurance and auto services in China, today reported annual financial...
WuXi AppTec Q1 2025 Revenue, Profit Resume Double Digit Growth, Revenue Up 21.0% YoY, Adjusted Non-IFRS Net Profit Up 40.0% YoY; Backlog for Continuing Operations Up 47.1% YoY
Total Revenue Reached RMB9.65 Billion, Up 21.0% Year-over-Year; among which Revenue from Continuing Operations Reached RMB9.39 Billion, Up 23.1% Year-over-Year Net Profit Attributable to the Owners of the Company Reached RMB3.67 Billion [1] , Up...
Xtep-- Market Leader in Global Running Shoe Sales and China's Marathon Event in 2024
XIAMEN, China, April 28, 2025 /PRNewswire/ -- With the increasing popularity of healthy lifestyles and the widespread promotion of fitness, the global athletic footwear and apparel market continues to expand, driven by rising consumer demand for...
TCL Electronics (01070.HK) Global TV Shipment and Sales Revenue Maintain High Growth in 2025Q1
Continued Product Mix Optimisation Yields Over 230% YoY Expansion in Global Shipment of Mini LED TV HONG KONG, April 27, 2025 /PRNewswire/ -- TCL Electronics Holdings Limited ("TCL Electronics" or the "Company", 01070.HK) today announced its global...
FOMO Pay Leverages BNY's Capability to Power GBP & EUR Cross-Border Payments
SINGAPORE, April 23, 2025 /PRNewswire/ -- FOMO Pay Pte Ltd ("FOMO Pay"), a Singapore-based major payment institution, has expanded its cross-border payment network, tapping into the clearing capabilities of The Bank of New York Mellon Corporation...
Financial Release: JOY GROUP Achieves 36% Revenue Growth to Reach US$483M in 2024 with Growth from Multi Beauty Categories
SHANGHAI, April 9, 2025 /PRNewswire/ -- JOY GROUP (Shanghai Juyi Cosmetics Co., Ltd.) has announced its financial results for the 2024 fiscal year, achieving total sales exceeding US$580M (RMB 4.2B), and annual revenue reaching US$483M (RMB 3.5B),...
Harbour BioMed Reports Full Year 2024 Financial Results
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 31, 2025 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics...
Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies
Key Highlights: Global first "immuno + anti-vascular" bispecific antibody approved: ivonescimab for EGFR-TKI resistant nsq-NSCLC. Phase III HARMONi study topline data expected mid-2025 (FDA FTD). ivonescimab outperforms pembrolizumab in Phase III...
Yanchang Petroleum International Announces 2024 Annual Results
Revenue and Profit of the Group Reached HK$29.18 Billion and HK$55.6 Million Respectively *** Novus ' o perating p erformance r emained r esilience Downstream oil and by-products trading business in China continued to growth Results Highlights : The...
WuXi XDC Achieved Another Remarkable Year with Extraordinary Business Performance and Financial Results for 2024
Revenue increased by 90.8% YoY to RMB 4,052 million Gross profit grew by 121.6% YoY to RMB 1,240 million, with its margin of 30.6%, a 4.3 percentage points increase compared to that of 2023 Net profit surged by 277.2% YoY to RMB 1,070 million, with...